Search clinical trials for: Mixed Hyperlipidemia
Total 4920 results
-
Novartis PharmaceuticalsNot yet recruitingMixed Dyslipidemia | Primary Hypercholesterolemia
-
Boryung Pharmaceutical Co., LtdRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaKorea, Republic of
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingPrimary Hypercholesterolaemia and Mixed DyslipidemiaChina
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Novartis PharmaceuticalsActive, not recruitingPrimary Hypercholesterolemia or Mixed DyslipidemiaChina
-
Eli Lilly and CompanyActive, not recruitingMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | HyperlipoproteinemiaUnited States, Mexico, Poland, Canada, Turkey, Japan, Argentina
-
Merck Sharp & Dohme LLCTerminatedMixed Dyslipidemia | Primary Hypercholesterolemia
-
Novartis PharmaceuticalsActive, not recruitingMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
Brigham and Women's HospitalActive, not recruitingASCVD | Hyperlipemia, MixedUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMixed Hyperlipidemia | Non-familial HypercholesterolemiaChina
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyWithdrawnMixed Dyslipidemia | Primary Hypercholesterolemia
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed HyperlipemiaChina
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
AmgenTerminatedMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
SanofiCompletedAtherosclerotic Cardiovascular Disease | Primary Hypercholesterolaemia and Mixed DyslipidaemiaGermany
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedHyperlipidemia | Mixed DyslipidemiaUnited States
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Organon and CoCompletedHypercholesterolemia | Hypertriglyceridemia | Hyperlipidemia
-
Organon and CoCompletedHypercholesterolemia | Hypertriglyceridemia
-
Organon and CoCompletedHypercholesterolemia | Hypertriglyceridemia
-
Korea United Pharm. Inc.Active, not recruiting
-
Misr University for Science and TechnologyActive, not recruiting
-
University of GuelphCanadian Agricultural Partnership Pulse Science Cluster Program; The Bonduelle...CompletedCardiovascular Diseases | HypercholesterolemiaCanada
-
National University, SingaporeNational University Health System, SingaporeCompletedPostprandial Hyperglycemia | LipidemiaSingapore
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Ache Laboratorios Farmaceuticos S.A.CompletedDyslipidemia | HypercholesterolemiaBrazil
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Merck Sharp & Dohme LLCCompletedMixed Dyslipidemia | Primary Hypercholesterolemia
-
Merck Sharp & Dohme LLCTerminatedMixed Dyslipidemia | Primary Hypercholesterolemia
-
AmgenCompletedDiabetes, Hyperlipidemia, Mixed DyslipidemiaUnited States, Canada, France, Korea, Republic of, China, Argentina, Russian Federation, Colombia, Turkey, Brazil
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
Merck Sharp & Dohme LLCCompletedPrimary Hypercholesterolemia | Mixed Hyperlipidemia
-
Merck Sharp & Dohme LLCCompletedMixed Hyperlipidemia
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
Merck Sharp & Dohme LLCTerminated
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
SingHealth PolyclinicsAgency for Science, Technology and ResearchUnknownHypertension | Diabetes Mellitus | Hyperlipidemia; MixedSingapore
-
Huazhong University of Science and TechnologyUnknown
-
PfizerCompleted
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina